Arixtra

Drug Details

Fondaparinux, also known by its brand name Arixtra, is an anticoagulant medication used to prevent and treat serious blood clots. It is particularly effective for managing clots in the legs (deep vein thrombosis or DVT) and lungs (pulmonary embolism or PE). Fondaparinux is typically administered alongside another blood thinner, such as warfarin, to enhance its effectiveness. This medication is crucial in preventing clots from traveling to vital organs, such as the lungs, heart, or brain, where they could cause significant health issues like breathing problems, heart attacks, or strokes. Fondaparinux works by blocking a protein called factor Xa, which plays a key role in blood clot formation. By inhibiting this protein, the drug effectively reduces the risk of clots forming in the body. It is often used as a preventive measure after surgeries that carry a high risk of blood clots, including hip fractures and knee or hip replacements. Administered as an injection under the skin once daily, the dosage of fondaparinux is determined based on the patient’s specific needs and body weight. While fondaparinux is generally safe, the most common side effect associated with its use is bleeding.